Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery (Q67133636)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery |
clinical trial |
Statements
A 24-week Double-blind Treatment and 24-week Follow-up, Randomized, Multicenter, Placebo-controlled, Phase IIa/IIb Study to Evaluate Safety and Efficacy of i.v. Bimagrumab on Total Lean Body Mass and Physical Performance in Patients After Surgical Treatment of Hip Fracture (English)
0 references
16 September 2014
0 references
14 May 2018
0 references
251
0 references
60 year
0 references